Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abercrombie & Fitch Co. (ANF) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

Abercrombie & Fitch Co.Trade
Marsh & McLennan Companies, Inc.Trade

Price performance (Past 24H)

Key statistics

Abercrombie & Fitch Co. vs Marsh & McLennan Companies, Inc. — how do they compare? Abercrombie & Fitch Co. trades at $108.67 (market cap $4.99B), while Marsh & McLennan Companies, Inc. trades at $188.85 (market cap $90.13B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 18.1× Abercrombie & Fitch Co.'s market cap, and Marsh & McLennan Companies, Inc. pays a 2.1% dividend while Abercrombie & Fitch Co. pays none. Which is the better fit depends on your goals.

ANFMRSH
Market Cap
$4.99B$90.13B
Sector
Consumer CyclicalFinancials
52-Week High
$129.85$211.21
52-Week Low
$65.61$157.32
Enterprise Value
$5.66B$110.81B
Dividend Yield
2.1%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abercrombie & Fitch Co.

ANF trades at $108.82, down 7.76% in the last session, amid mixed signals. The stock shows strong fundamentals with a P/E of 10.85 and robust profitability margins, including a net income margin of 9.34%. Recent earnings beats and a bullish technical trend, supported by moving averages, contrast with neutral oscillators. Key resistance lies at $117, near the consensus price target. Q2 2026 earnings on August 26, 2026, are a focal point, with expectations set at $1.99 EPS.

Outlook is cautiously optimistic due to solid earnings growth and institutional buying, but risks include market volatility and competitive pressures. The stock offers value with upside to the $117.75 target, though sentiment is divided among analysts. Investors should weigh strong cash flows against recent price declines and macroeconomic uncertainties.

Marsh & McLennan Companies, Inc.

Marsh (MRSH) trades at $188.69, down 1.34% on the day, with a bullish technical signal supported by moving averages and an oversold RSI. The company reported strong Q2 2026 earnings, beating estimates with $2.96 EPS, and maintains solid fundamentals including a 14.24% net income margin and 25.72% ROE. Recent acquisitions, such as MMA's deal for Accel, highlight strategic growth initiatives.

The outlook remains positive with a consensus price target of $202.89, though risks include margin pressure from rising expenses and soft P&C pricing. Institutional activity shows mixed positions, with Bank of America reducing holdings while others like Ashton Thomas Securities added new stakes, reflecting cautious optimism.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abercrombie & Fitch Co.

Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumer through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.

Read more on ANF

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH